Compare Snap On Incorporated (SNA) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snap On Incorporated vs Tenet Healthcare Corporation — how do they compare? Snap On Incorporated trades at $360.27 (market cap $18.56B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Snap On Incorporated and Tenet Healthcare Corporation are close in size by market cap, and Snap On Incorporated pays a 2.72% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Snap On Incorporated for 36 Days and Tenet Healthcare Corporation for 15 Days on average.
| SNA | THC | |
|---|---|---|
Market Cap | $18.56B | $20.98B |
Volume | 401,326 | 428,008 |
Sector | Industrials | Health |
52-Week High | $419.31 | $280.77 |
52-Week Low | $327.33 | $161.37 |
Typical Hold Time | 36 Days | 15 Days |
Enterprise Value | $18.20B | $32.06B |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snap-on Incorporated (SNA) trades at $359.89, down 2.37% on the day, with a bearish technical signal from moving averages and oscillators. Fundamentally, the company maintains strong profitability with a 19.6% net income margin and a 17.58% ROE, though Q1 2026 earnings slightly missed expectations. Recent news highlights gross margin expansion and institutional position adjustments.
The outlook is supported by analyst consensus with a $449 price target and 66.7% buy ratings, but risks include valuation premiums and mixed segment trends. Earnings growth from innovation and RCI initiatives remains a key catalyst, though integration costs and softer OEM demand pose execution risks.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
